Cargando…

The Role of Interleukin-6 Family Members in Cardiovascular Diseases

Cardiovascular disease is one of the main causes of human mortality. Cytokines play crucial roles in the development of cardiovascular disease. Interleukin (IL)-6 family members are a series of cytokines, including IL-6, IL-11, IL-30, IL-31, OSM, LIF, CNTF, CT-1, CT-2, and CLC, that regulate multipl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yongqi, Ye, Di, Wang, Zhen, Pan, Heng, Lu, Xiyi, Wang, Menglong, Xu, Yao, Yu, Junping, Zhang, Jishou, Zhao, Mengmeng, Xu, Shuwan, Pan, Wei, Yin, Zheng, Ye, Jing, Wan, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983865/ https://www.ncbi.nlm.nih.gov/pubmed/35402550 http://dx.doi.org/10.3389/fcvm.2022.818890

Ejemplares similares

MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice
por: Wang, Menglong, et al.
Publicado: (2022)

IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
por: Liu, Menglin, et al.
Publicado: (2022)

The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022)

Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
por: Ye, Jing, et al.
Publicado: (2020)

The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Wang, Menglong, et al.
Publicado: (2023)

Il12a Deletion Aggravates Sepsis-Induced Cardiac Dysfunction by Regulating Macrophage Polarization
por: Wang, Zhen, et al.
Publicado: (2021)

The Association between Obesity and Severity in Patients with Coronavirus Disease 2019: a Retrospective, Single-center Study, Wuhan
por: Zhang, Jishou, et al.
Publicado: (2021)

Decreased Low-Density Lipoprotein Cholesterol Level Indicates Poor Prognosis of Severe and Critical COVID-19 Patients: A Retrospective, Single-Center Study
por: Zhao, Mengmeng, et al.
Publicado: (2021)

Advances in the relationship between coronavirus infection and cardiovascular diseases
por: Zhao, Mengmeng, et al.
Publicado: (2020)

Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial infarction
por: Pan, Kunming, et al.
Publicado: (2023)

Effect of Cytochrome P450 Family 2 Subfamily R Member 1 Variants on the Predisposition of Coronary Heart Disease in the Chinese Han Population
por: Wang, Qi, et al.
Publicado: (2021)

Microglia‐Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction
por: Wang, Menglong, et al.
Publicado: (2023)

The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis
por: Ye, Jing, et al.
Publicado: (2020)

The expression of interleukin-25 increases in human coronary artery disease and is associated with the severity of coronary stenosis
por: Xu, Yao, et al.
Publicado: (2020)

Insights into bone morphogenetic proteins in cardiovascular diseases
por: Ye, Di, et al.
Publicado: (2023)

IL-30 protects against sepsis-induced myocardial dysfunction by inhibiting pro-inflammatory macrophage polarization and pyroptosis
por: Zhao, Mengmeng, et al.
Publicado: (2023)

Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases
por: Wang, Menglong, et al.
Publicado: (2022)

Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice
por: Ye, Jing, et al.
Publicado: (2020)

The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges
por: Wang, Zhen, et al.
Publicado: (2019)

The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury
por: Zhang, Jishou, et al.
Publicado: (2020)

Case Report: Danon Disease: Six Family Members and Literature Review
por: Wang, Yuanyuan, et al.
Publicado: (2022)

Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study
por: Wang, Zhen, et al.
Publicado: (2020)

Developing a Hybrid Risk Assessment Tool for Familial Hypercholesterolemia: A Machine Learning Study of Chinese Arteriosclerotic Cardiovascular Disease Patients
por: Wang, Lei, et al.
Publicado: (2022)

Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress
por: Wang, Menglong, et al.
Publicado: (2022)

Editorial: Frontiers in Cardiovascular Medicine: Rising Stars 2021
por: Wang, Lijun, et al.
Publicado: (2022)

Cardiovascular magnetic resonance findings in Danon disease: a case series of a family
por: Liu, Xiaolong, et al.
Publicado: (2023)

Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
por: Ye, Jing, et al.
Publicado: (2020)

Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis
por: Ye, Zhen, et al.
Publicado: (2022)

The value of myocardial work in the estimation of left ventricular systolic function in patients with coronary microvascular disease: A study based on adenosine stress echocardiography
por: Liu, Quande, et al.
Publicado: (2023)

Editorial: Highlights in General Cardiovascular Medicine: 2021
por: Wang, Lijun, et al.
Publicado: (2022)

Editorial: The Serpin Family in the Cardiovascular System
por: Bouton, Marie-Christine, et al.
Publicado: (2022)

Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study
por: Kolovou, Vana, et al.
Publicado: (2018)

Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia
por: Wang, Yaodong, et al.
Publicado: (2022)

Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States
por: Zhai, Yinghong, et al.
Publicado: (2021)

Cardiovascular health control in the family health strategy
por: Tavares, Gilberto Andrade, et al.
Publicado: (2022)

Recent progress of antiviral therapy for coronavirus disease 2019
por: Zhao, Mengmeng, et al.
Publicado: (2021)

The Clinical Characteristics and Prognosis Factors of Mild-Moderate Patients With COVID-19 in a Mobile Cabin Hospital: A Retrospective, Single-Center Study
por: Zhang, Jishou, et al.
Publicado: (2020)

Modification effect of changes in cardiometabolic traits in association between kidney stones and cardiovascular events
por: Xu, Min, et al.
Publicado: (2022)

The role of post-translational modifications in driving abnormal cardiovascular complications at high altitude
por: Hou, Jun, et al.
Publicado: (2022)

Cardiovascular Complications of COVID-19 Vaccines
por: Liu, Runyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_spu20r59e39oa02e6f8n4nmksd